USPTO serial 86983758
ONCOTRIALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 1, 2018
- Examiner
- BLACK, MILDRED ELIZABETH
- Law office
- TMO LAW OFFICE 121
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ONCOTRIALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY, US
COLUMBUS, OH, US
New York, NY, US
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Perry J. Viscounty
Perry J. Viscounty Latham & Watkins LLP650 Town Center Drive, Suite 2000Costa Mesa, CA 92626United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Management and compilation of computerized databases; Electronic data collection and data submission services for business purposes in the fields of oncology, medicine, life science and healthcare; Collection and compilation of information into computer databases in the fields of oncology, medicine, life science and healthcare; Business consulting and management in the field of patient data, namely, management and compilation of computerized databases in the field of oncology patient data for business purposes; Providing an on-line database providing business intelligence in the fields of oncology, medicine, life science and healthcare; Managing databases for the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Managing databases for data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures | ACTIVE | Sep 29, 2015 |
| 042 | Data mining; Providing temporary use of on-line non-downloadable cloud computing software for in aggregating, integrating, analyzing, standardizing, managing and reporting of data in clinical trials, clinical data, financial data, electronic medical records data, medical practice management data and billing data in real time from heterogeneous data sources, and for database management in the fields of oncology, medicine, life science and healthcare; Providing temporary use of on-line non-downloadable cloud computing software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Providing temporary use of on-line non-downloadable cloud computing software for use in analyzing business and clinical intelligence data in the fields of fields of oncology, medicine, life science and healthcare; Providing temporary use of on-line non-downloadable cloud computing software for data compilation for research purposes in the fields of oncology, medicine, life science and healthcare; Development, updating and maintenance of software and databases in the fields of oncology, medicine, life science and healthcare; Providing temporary use of on-line non-downloadable cloud computing software for use in design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Providing temporary use of on-line non-downloadable cloud computing software for the tracking and management of patients, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Application service provider, namely, hosting, managing, developing, and maintaining web sites, software, applications, and databases for data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Application service provider, namely, hosting, managing, developing, and maintaining web sites, software, and applications for the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Application service provider, namely, hosting, managing, developing, and maintaining web sites, software, and applications for the tracking and management of patients, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures | ACTIVE | Sep 29, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Flatiron Health, Inc.
- Other trademarks owned by PARADIGM HEALTH, INC.
- Other trademarks owned by Flatiron Health, Inc.
- Other trademarks owned by Flatiron Health, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ONCOTRIALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 23, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 23, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 23, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 23, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 20, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 6, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 6, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 6, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 12, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 1, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 1, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 1, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 9, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 9, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 9, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 9, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 9, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 1, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 28, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 27, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 16, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 16, 2018 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Mar 12, 2018 | IUAF | USE AMENDMENT FILED | — |
| Mar 12, 2018 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Mar 12, 2018 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Mar 12, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 6, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 2, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 2, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 2, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 2, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 1, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 1, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 25, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 25, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 3, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 7, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 10, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 10, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 21, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 3, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 23, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 22, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 22, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 22, 2016 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 7, 2016 | ALIE | ASSIGNED TO LIE | — |
| Oct 26, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 26, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Jan 12, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 7, 2016 | NWAP | NEW APPLICATION ENTERED | — |